1. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis;C, LeRoy E.; M, Black C.; R, Fleischmajer;J Rheunatol,1988
2. Associations between T cell antigen receptor gamma gene restriction, fragment length polymorphism and progressive systemic sclerosis;E, Kratz L.; A, Bongham J.; W, Needleman B.;Arthritis Rhewm,1989
3. Interleukin-2 in sclerodermacorrelation of serum level with extent of skin involvement and disease duration;B, Kahaleh M.; C, LeRoy E.;Ann Intern Med,1989
4. Prolonged alkylating drug therapy is beneficial in systemic scleroderma;H, Mackenzie A.;Arthritis Rhewn,1970
5. Chlorambucil in the treatment of progressive systemic sclerosis;C, Steigerwald J.,1985